Bococizumab is a novel anti-PCSK9 antibody specifically developed to address hypercholesterolemia. Such therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol concentrations. By https://ztndz.com/story27960056/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia